---
title: "Zhongyu Energy Discloses Share Repurchase in Next-Day HKEX Return"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302852257.md"
description: "Zhongyu Energy Holdings Limited repurchased 400,000 shares for HKD 1.08 million on October 23, 2026. The purchase price ranged from HKD 2.68 to HKD 2.715 per share. All repurchased shares will be held as treasury shares."
datetime: "2026-10-23T09:15:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302852257.md)
  - [en](https://longbridge.com/en/news/302852257.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302852257.md)
generator: "portal-rs"
---

# Zhongyu Energy Discloses Share Repurchase in Next-Day HKEX Return

-   Zhongyu Energy repurchased 400,000 shares for HKD 1.08 million on October 23, 2026. \* Repurchase prices ranged from HKD 2.68 to HKD 2.715 per share. All repurchased shares will be held as treasury shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhongyu Energy Holdings Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261023-12381262), on October 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [03633.HK](https://longbridge.com/en/quote/03633.HK.md)

## Related News & Research

- [Zhongyu Energy discloses share buyback in HKEX next-day return](https://longbridge.com/en/news/302408662.md)
- [Zhongyu Energy: Turnover and profit fell, but margins and non-HKFRS profit improved; focus shifts to smart energy](https://longbridge.com/en/news/297171964.md)
- [Jim Cramer says Nvidia’s leadership shake-up won’t derail the AI trade](https://longbridge.com/en/news/305736094.md)
- [China Accepts Akeso’s Ivonescimab Application for Biliary Tract Cancer](https://longbridge.com/en/news/305757945.md)
- [Coatue Raises Share Stake In Microsoft, Nvidia, Intel and SpaceX](https://longbridge.com/en/news/305663248.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**